UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeting autoimmune mechanisms by precision medicine in Myasthenia Gravis

Frontiers in immunology, 2024-06, Vol.15, p.1404191

2024

Volltextzugriff (PDF)

Toll‐like receptors 7 and 9 in myasthenia gravis thymus: amplifiers of autoimmunity?

Annals of the New York Academy of Sciences, 2018-02, Vol.1413 (1), p.11-24

2018

Volltextzugriff (PDF)

miR-146a in Myasthenia Gravis Thymus Bridges Innate Immunity With Autoimmunity and Is Linked to Therapeutic Effects of Corticosteroids

Frontiers in immunology, 2020-03, Vol.11, p.142

2020

Volltextzugriff (PDF)

FM19G11-loaded nanoparticles modulate energetic status and production of reactive oxygen species in myoblasts from ALS mice

Biomedicine & pharmacotherapy, 2024-04, Vol.173, p.116380-116380, Article 116380

2024

Volltextzugriff (PDF)

Etiology of myasthenia gravis: Innate immunity signature in pathological thymus

Autoimmunity reviews, 2013-07, Vol.12 (9), p.863-874

2013

Volltextzugriff (PDF)

Complement Inhibition for the Treatment of Myasthenia Gravis

ImmunoTargets and therapy, 2020-01, Vol.9, p.317-331

2020

Volltextzugriff (PDF)

MiR-146a in ALS: Contribution to Early Peripheral Nerve Degeneration and Relevance as Disease Biomarker

International journal of molecular sciences, 2023-02, Vol.24 (5), p.4610

2023

Volltextzugriff (PDF)

Identification of a cytokine profile in serum and cerebrospinal fluid of pediatric and adult spinal muscular atrophy patients and its modulation upon nusinersen treatment

Frontiers in cellular neuroscience, 2022-08, Vol.16, p.982760-982760

2022

Volltextzugriff (PDF)

Diagnosis and treatment of myasthenia gravis

Current opinion in rheumatology, 2019-11, Vol.31 (6), p.623-633

2019

Volltextzugriff (PDF)

Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients

International journal of molecular sciences, 2021-05, Vol.22 (11), p.5673

2021

Volltextzugriff (PDF)

Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus

Annals of neurology, 2010-06, Vol.67 (6), p.726-738

2010

Volltextzugriff (PDF)

Non-Coding RNAs in Myasthenia Gravis: From Immune Regulation to Personalized Medicine

Cells (Basel, Switzerland), 2024-09, Vol.13 (18), p.1550

2024

Volltextzugriff (PDF)

The thymus in myasthenia gravis: Site of "innate autoimmunity"?

Muscle & nerve, 2011-10, Vol.44 (4), p.467-484

2011

Volltextzugriff (PDF)

A novel infection- and inflammation-associated molecular signature in peripheral blood of myasthenia gravis patients

Immunobiology (1979), 2016-11, Vol.221 (11), p.1227-1236

2016

Volltextzugriff (PDF)

Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein–Barr virus infection

Immunobiology (1979), 2016-04, Vol.221 (4), p.516-527

2016

Volltextzugriff (PDF)

Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations

Frontiers in immunology, 2021-06, Vol.12, p.667336-667336

2021

Volltextzugriff (PDF)

Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator?

Oncotarget, 2017-11, Vol.8 (56), p.95432-95449

2017

Volltextzugriff (PDF)

Human leukocyte antigen variants associate with BNT162b2 mRNA vaccine response

Communications medicine, 2024-04, Vol.4 (1), p.63-63, Article 63

2024

Volltextzugriff (PDF)

Eculizumab for the treatment of myasthenia gravis

Expert opinion on biological therapy, 2020-09, Vol.20 (9), p.991-998

2020

Volltextzugriff (PDF)

Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy

Biomedicines, 2022-06, Vol.10 (6), p.1360

2022

Volltextzugriff (PDF)

Muscle and Muscle-like Autoantigen Expression in Myasthenia Gravis Thymus: Possible Molecular Hint for Autosensitization

Biomedicines, 2023-02, Vol.11 (3), p.732

2023

Volltextzugriff (PDF)

COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease

Annals of clinical and translational neurology, 2021-12, Vol.8 (12), p.2314-2318

2021

Volltextzugriff (PDF)

Can early-onset acquired demyelinating syndrome (ADS) hide pediatric Behcet's disease? A case report

Frontiers in pediatrics, 2023-06, Vol.11, p.1175584

2023

Volltextzugriff (PDF)

FM19G11-Loaded Gold Nanoparticles Enhance the Proliferation and Self-Renewal of Ependymal Stem Progenitor Cells Derived from ALS Mice

Cells (Basel, Switzerland), 2019-03, Vol.8 (3), p.279

2019

Volltextzugriff (PDF)

Myasthenia gravis: from autoantibodies to therapy

Current opinion in neurology, 2018-10, Vol.31 (5), p.517-525

2018

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(127)

Publikationsform

Artikel
(147)
Berichte
(3)
Bücher
(1)

Sprache

Englisch
(137)
Portugiesisch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Targeting autoimmune mechanisms by precision medicine in Myasthenia Gravis

Toll‐like receptors 7 and 9 in myasthenia gravis thymus: amplifiers of autoimmunity?

miR-146a in Myasthenia Gravis Thymus Bridges Innate Immunity With Autoimmunity and Is Linked to Therapeutic Effects of Corticosteroids

FM19G11-loaded nanoparticles modulate energetic status and production of reactive oxygen species in myoblasts from ALS mice

Etiology of myasthenia gravis: Innate immunity signature in pathological thymus

Complement Inhibition for the Treatment of Myasthenia Gravis

MiR-146a in ALS: Contribution to Early Peripheral Nerve Degeneration and Relevance as Disease Biomarker

Identification of a cytokine profile in serum and cerebrospinal fluid of pediatric and adult spinal muscular atrophy patients and its modulation upon nusinersen treatment

Diagnosis and treatment of myasthenia gravis

Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients

Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus

Non-Coding RNAs in Myasthenia Gravis: From Immune Regulation to Personalized Medicine

The thymus in myasthenia gravis: Site of "innate autoimmunity"?

A novel infection- and inflammation-associated molecular signature in peripheral blood of myasthenia gravis patients

Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein–Barr virus infection

Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations

Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator?

Human leukocyte antigen variants associate with BNT162b2 mRNA vaccine response

Eculizumab for the treatment of myasthenia gravis

Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy

Muscle and Muscle-like Autoantigen Expression in Myasthenia Gravis Thymus: Possible Molecular Hint for Autosensitization

COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease

Can early-onset acquired demyelinating syndrome (ADS) hide pediatric Behcet's disease? A case report

FM19G11-Loaded Gold Nanoparticles Enhance the Proliferation and Self-Renewal of Ependymal Stem Progenitor Cells Derived from ALS Mice

Myasthenia gravis: from autoantibodies to therapy

Suchergebnisse filtern